ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2011. Rejuvenation Res, 2011; 14:227–231.
2.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2011. Rejuvenation Res, 2011; 14:341–345.
3.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2011. Rejuvenation Res, 2011; 14:443–447.
4.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2011. Rejuvenation Res, 2011; 14:561–565.
5.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2011. Rejuvenation Res, 2011; 14:685–690.
6.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2012. Rejuvenation Res, 2012; 15:102–107.
7.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2012. Rejuvenation Res, 2012; 15:629–630.
8.
KangS, Fernandes-AlnemriT, AlnemriES. A novel role for the mitochondrial HTRA2/OMI protease in aging. Autophagy, 2013; 9:420–421.
9.
VincowES, MerrihewG, ThomasRE, ShulmanNJ, BeyerRP, MacCossMJ, PallanckLJ. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci USA, 2013; 110:6400–6405.
10.
de GreyAD. How is mutant mitochondrial DNA clonally amplified? Much new evidence, still no answers. Rejuvenation Res, 2009; 12:217–219.
11.
KuriharaY, KankiT, AokiY, HirotaY, SaigusaT, UchiumiT, KangD. Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J Biol Chem, 2012; 287:3265–3272.
12.
de GreyAD. Mitochondrial gene therapy: An arena for the biomedical use of inteins. Trends Biotechnol, 2000; 18:394–399.
13.
O'ConnorMS, SwaminathanG, FazalS, JonesT, de GreyADNJ. MitoSENS: Allotopic expression of mitochondrial genes using a co-translational import strategy. Rejuvenation Res, 2011; 14:S77.
14.
de GreyAD. Protagonistic pleiotropy: Why cancer may be the only pathogenic effect of accumulating nuclear mutations and epimutations in aging. Mech Ageing Dev, 2007; 128:456–459.
15.
JohnsonAA, AkmanK, CalimportSR, WuttkeD, StolzingA, de MagalhãesJP. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res, 2012; 15:483–494.
16.
GravinaS. Epigenetic drift and aging. Rejuvenation Res, 2011; 14:S35.
17.
FischerHG, MorawskiM, BrücknerMK, MittagA, TarnokA, ArendtT. Changes in neuronal DNA content variation in the human brain during aging. Aging Cell, 2012; 11:628–633.
LutzV, SattlerM, GallinatS, WenckH, PoertnerR, FischerF. Impact of collagen crosslinking on the second harmonic generation signal and the fluorescence lifetime of collagen autofluorescence. Skin Res Technol, 2012; 18:168–179.
23.
YamagishiS. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders. Rejuvenation Res, 2012; 15:564–572.
24.
PriceSJ, TozerDJ, GillardJH. Methodology of diffusion-weighted, diffusion tensor and magnetisation transfer imaging. Br J Radiol, 2011; 84,Spec No 2:S121–S126.
25.
SchladtTD, SchneiderK, SchildH, TremelW. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton Trans, 2011; 40:6315–6343.
